BRCA 2023: Moving Into the Mainstream

BRCA 2023: Moving Into the Mainstream represents a unique opportunity to look at all aspects of breast and ovarian cancer, and in particular the susceptibility genes, BRCA1 and BRCA2, which are responsible for a considerable fraction of early-onset breast cancer.

Clinicians and researchers from over 30 countries will gather for the ninth edition of this event which has come to be recognized as THE major international conference in the world that covers specific targeted therapies for hereditary cancer.

Topics covered will include population-based testing for HBOC-related genes, new approaches to the early diagnosis of hereditary cancers, new developments in HBOC management, polygenic risk scores, and special round tables on disparities in hereditary cancer genetics and mainstreaming genetic testing for HBOC, to name just a few.

For those potential participants who can not or do not wish to attend in person, we are offering the opportunity to participate through the live streaming of most of the scientific symposium.

All sessions taking place in the main auditorium will be live streamed. These sessions will include all lectures as well as the most popular SIG on each day.